HRMY · Harmony Biosciences Holdings Inc
United States · RS rating 78 · As of 2026-10-14
| Price | 37.51 USD |
|---|---|
| 1-day change | +1.3% |
| RS rating (overall / 1M / 3M / 12M) | 78 / 21 / 87 / 87 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 32 / 40 / 18 |
| Industry group (rank) | Medical-Biomed/Biotech (167) |
| EPS growth Q/Q | -56.3% |
| Sales growth Q/Q | +1.8% |
| Distance from 52-week high | +12.5% |
| Market cap (USD) | $1.9B |